Takeda Pharmaceutical (TAK) Cost of Revenue (2025)
Takeda Pharmaceutical has reported Cost of Revenue over the past 1 years, most recently at $2.6 billion for Q4 2025.
Takeda Pharmaceutical has reported Cost of Revenue over the past 1 years, most recently at $2.6 billion for Q4 2025.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month